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Objective: The association between obesity and coronary heart disease (CHD) may have changed over
time, for example due to improved pharmacological treatment of CHD risk factors. This meta-analysis of
31 prospective cohort studies explores the influence of calendar period on CHD risk associated with
body mass index (BMI).
Design and Methods: The relative risks (RRs) of CHD for a five-BMI-unit increment and BMI categories
were pooled by means of random effects models. Meta-regression analysis was used to examine the
influence of calendar period (>1985 v 1985) in univariate and multivariate analyses (including mean
population age as a covariate).
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Results: The age, sex, and smoking adjusted RR (95% confidence intervals) of CHD for a five-BMI-unit
increment was 1.28(1.22:1.34). For underweight, overweight and obesity, the RRs (compared to normal
weight) were 1.11(0.91:1.36), 1.31(1.22:1.41), and 1.78(1.55:2.04), respectively. The univariate analysis
indicated 31% (95%CI: 56:0) lower RR of CHD associated with a five-BMI-unit increment and a 51%
(95%CI: 78: 14)) lower RR associated with obesity in studies starting after 1985 (n ¼ 15 and 10,
respectively) compared to studies starting in or before 1985 (n ¼ 16 and 10). However, in the multivariate
analysis, only mean population age was independently associated with the RRs for a five-BMI-unit
increment and obesity (29(95%CI: 55: 5)) and 31(95%CI: 66:3), respectively) per 10-year
increment in mean age).
Conclusion: This study provides no consistent evidence for a difference in the association between BMI
and CHD by calendar period. The mean population age seems to be the most important factor that
modifies the association between the risk of CHD and BMI, in which the RR decreases with increasing
age.
Obesity (2013) 21, 865-880. doi:10.1002/oby.20043
Introduction
The prevalence of both overweight and obesity has increased world-
wide over the past decades, especially after the 1980s in Europe and
the USA (1-3). This is a major concern because obesity is associated
with increased mortality, disability, decreased quality of life, high
health care costs, and morbidity including coronary heart disease
(CHD) (1,4).
Despite the rise in the prevalence of obesity, CHD mortality rates
have declined since the 1960s-1970s in Western Europe, Australia
and the USA (5,6). This decline can be explained by major improve-
ments in coronary treatments and CHD management since the mid
1980s and by changes in risk factors—even in overweight and obese
persons—such as a decrease in the prevalence of smoking, and in
blood pressure and cholesterol levels (7-10). Additional in this pe-
riod, the lifestyle approach was advocated within health-care proce-
dures to combat CHD (11,12). Because of all these developments,
we expected that the risk of incidence and mortality of CHD associ-
ated with being overweight or obese has decreased over time.
The impact of time on CHD risk associated with obesity in adults
has not been examined in a large meta-analysis before. Knowledge
of time-dependent shifts in CHD risk associated with obesity not
only provides indirect ‘‘evidence’’ for improved health care proce-
dures in the obese, but is also important for forecasting future deaths
from chronic diseases, as presented in leading publications (13,14).
This in turn is fundamental for underpinning the needs for policies
on obesity and CVD management.
The present meta-analysis, including 31 prospective cohort studies from
various countries, comprising 389,212 persons, examined the influence
of calendar period (the year in which the study started) on the associa-
tion between BMI and CHD, adjusted for age, sex and smoking. The
analysis took additional study characteristics (i.e., mean age of the pop-
ulation and length of follow-up) into account that have been proposed
to influence the association between body weight and CHD (15,16). To
test for the impact of changes in risk factors over time (induced by
treatment developments), we additionally examined the influence of
calendar period on the association between BMI and CHD in a subset
of 21 cohort studies with additional adjustments for physical activity,
blood pressure and cholesterol. We expected that the influence of calen-
dar period would be attenuated by adjusting for CHD risk factors.
Methods
Data sources, study selection and data extraction were previously
described in detail (17). Briefly, studies were identified by a
PubMed/Medline search until 2007 by using the following search
strategy: obesity, body mass index, BMI, or overweight in either the
title or in the Medical Subject Heading (MeSH) and either coronary
heart disease in the title or coronary disease in MeSH, plus either
prospective or cohort. Also, we examined reference lists of identi-
fied articles, and got suggestions through colleagues. Eligible studies
were prospective cohort studies conducted in healthy, mainly Cauca-
sian populations. Seventy cohort studies were identified and 62
investigators were contacted of whom 31 agreed to participate. The
31 cohort studies had data available on BMI, age, sex and smoking
and CHD incidence or mortality. Eighteen studies used mortality
from CHD and 13 studies used incidence of CHD (both fatal and
non-fatal events) as their endpoint. Twenty-one studies had extra
data available on physical activity, blood pressure and cholesterol.
The investigators from the participating cohort studies were
requested to calculate hazard ratios (further on called relative risks
(RR)) of CHD for BMI and their 95% confidence intervals (CIs)
with systematic adjustments for age, sex and smoking, and if avail-
able also for physical activity, blood pressure, and cholesterol levels.
Data synthesis
In this study, we examined the influence of calendar period on the
pooled RR for BMI as a continuous variable (i.e., risk per five units
increase in BMI; N ¼ 31) as well as for BMI-categories (i.e., cate-
gories underweight (<18.5 kg m2; N ¼ 17), overweight (25.0-29.9
kg m2; N ¼ 20) and obesity (30.0 kg m2; N ¼ 20), as compared
to the reference category (18.5-24.9 kg m2)). For the 10 studies
which only provided RRs for BMI categories, the RRs were trans-
formed to their continuous form for each set of adjustments by
applying the method of Greenland and Longnecker (18), using the
numbers of cases as observed rather than their fitted values (19).
The adjusted RRs for BMI were plotted to visualize variation in
results between studies.
Calendar period was calculated by using the baseline year of each
cohort study. Recruitment and data collection at baseline took in
most cohort studies more than 1 year. Therefore, baseline year was
defined as the mean of the first year and last year in which baseline
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measurements were conducted. The studies were then divided into
two strata to examine whether the pooled RRs differed by calendar
period (1985 and >1985). The 1985 cut-point chosen, corre-
sponded with the period when major changes occurred regarding the
management of CHD and the increase in advocating lifestyle
approaches within health-care procedures (7-12). Furthermore, the
influence of other important study characteristics on the association
between BMI and CHD, i.e. age of the population (defined as the
mean age of the population at baseline) and length of follow-up
(defined as the mean length in years the population was followed to
their endpoint) were examined.
Statistical analysis
Descriptive statistics were used to describe the main characteristics
of the cohort studies, i.e., baseline year, mean age of the population
and length of follow-up.
The age, sex, and smoking adjusted log RRs for BMI as a continuous
and categorical variable were pooled by means of a random effects
model (20), using the MIXED procedure in SAS (version 9.1). The
pooled RR and the 95% confidence interval (95%CI) was estimated
by exponentiating the results from this model. Heterogeneity of RRs
between cohort studies was tested using chi-squared tests.
To determine sensitivity of the results, meta-analyses with 30 studies
(continuous BMI) and with 16 and 19 studies (BMI categories) were
performed, leaving repeatedly each individual study out of the
pooled risk. Further, to check for potential bias due to misclassifica-
tion of BMI based on self-reported weight and height, analyses were
repeated after excluding cohorts with self-reported BMI. This meant
exclusion of four studies in the analysis for continuous BMI, over-
weight, and obesity and three studies for underweight. Publication
bias was investigated using a funnel plot.
To examine the influence of calendar period (>1985 vs. 1985),
age of the population and length of follow-up (expressed per 10
year increment), a meta-regression analysis (including the random
effects model) was used. In this meta-regression analysis, the age,
sex, and smoking adjusted log RR of the studies was regressed onto
the study characteristics. This was done by using a univariate (i.e.,
calendar period, age and length of follow-up in separate models)
and a multivariate analysis (i.e., calendar period and age of the pop-
ulation adjusted for each other). Calendar period and length of fol-
low-up were not simultaneously entered into the model to prevent
multicollinearity since baseline year and length of follow-up were
highly correlated (Pearson’s r ¼ 0.86; P < 0.001). Similar models
were used for the categories underweight, overweight and obesity.
These analyses were then repeated in a subset of cohort studies
(continuous BMI: N ¼ 21, underweight: N ¼ 12, overweight and
obesity: N ¼ 14) with log RRs additionally adjusted for physical ac-
tivity, blood pressure and cholesterol.
The influence of study characteristics is reported as a percentage
change of the RR of CHD associated with BMI by the study charac-
teristic term. To give insight in how the percentage change was cal-
culated, we present the following hypothetical example:
Suppose the regression coefficients for the log(RR) are 0.3 for the
intercept and 0.1 for the calendar period effect. In that case, the
RR of studies starting before and in 1985 is e0.3 ¼ 1.35 and the RR
for studies starting after 1985 is e(0.3þ0.1) ¼ 1.22. This gives a
percentage change of ((1.22  1)  ((1.35  1))/(1.35  1) 
100% ¼ 37%. To indicate whether the influence of a study char-
acteristic was statistically significant, the accompanying 95% confi-
dence intervals are presented.
Results
Characteristics of cohorts
Table 1 presents the characteristics of the study populations, com-
prising a total of 389,212 persons. During follow-up in total 20 652
CHD events were observed. Some studies provided RRs for a longer
length of follow-up than in the original articles. The cohorts used
for analysis regarding BMI categories are marked in Table 1.
Table 2 presents the descriptive statistics of baseline year, age of
the population and length of follow-up. For the earlier studies
(1985), age of the population was lower in comparison with the
later studies (>1985). The length of follow-up was longer for the
earlier studies.
Relative risks of CHD associated with BMI
For the 31 studies, the age, sex, and smoking adjusted RR of CHD
was increased for a five-BMI-unit increment, overweight and obesity
(Table 3). Underweight was not associated with the risk of CHD
(RR 1.11 (0.91:1.36). After adjustment for physical activity, blood
pressure and cholesterol, the RRs for a five-BMI-unit increment,
overweight and obesity were lower but still significant as reported
previously (17).
There was substantial heterogeneity between study results of the 31
cohorts (P < 0.001; Figure 1) and between the study results for
each BMI category (P < 0.05; not shown). The sensitivity analysis
indicated no strong influence by individual studies as the change in
RR of CHD associated with BMI ranged maximally from 0.08 to
0.06 when single studies were excluded. Exclusion of studies that
used self-reported BMI resulted in somewhat lower RRs in the
remaining cohorts concerning increasing BMI, underweight, over-
weight and obesity (respectively, 1.26 (1.20:1.32); 1.09 (0.84:1.42);
1.26 (1.18:1.35); 1.66 (1.45:1.91)).
The funnel plot suggested that studies with higher estimates of rela-
tive risk were not overrepresented, suggesting that there was no pub-
lication bias using the 31 cohorts (Appendix 1).
Influence of calendar period and other factors on
the relative risk of CHD for BMI
The relationships between study characteristics and the RR of CHD
associated with BMI as a continuous and categorical variable are
graphically displayed in Appendix 2.
Table 3 presents the percentage changes in the RR of CHD associ-
ated with BMI by calendar period, age of the population and length
of follow-up for the univariate and multivariate meta-regression
analyses. Because underweight was not associated with CHD, the
influences of the study characteristics were not examined for this
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category. Table 4 presents the RRs of CHD associated with continu-
ous and categorical BMI stratified by calendar period.
Relative risks adjusted for age, sex, and smoking. The differ-
ence in the RR of CHD for a five-BMI-unit increment and obesity
between calendar periods, that was observed in the univariate analy-
sis (31% (95%CI: 56:0) and 51% (95%CI: 78: 14), respec-
tively) (Tables 3 and 4), was no longer observed in the multivariate
analysis (Table 3). However, in the multivariate analysis, age of the
population still (near) significantly lowered the RR by 29% (95%CI:
55: 5) and 31% (95%CI: 66:3) respectively for each 10-year
increase in age of the population (Table 3). No interaction effect
between calendar period and mean age was found.
Length of follow-up (only examined in the univariate analysis) had
a significant influence on the RR associated with a five-BMI-unit in-
crement (þ25% (95%CI: 0:52)) and with obesity (þ53% (95%CI:
9-109)) (Table 3).
We repeated these analyses in a subset of studies (N ¼ 13; N ¼ 6
1985; N ¼ 7 >1985) with a length of follow-up between 10 and
19.9 years to reduce correlation between baseline year and length of
follow-up (Pearson’s r ¼ 0.48, P ¼ 0.10) and overlap in time
TABLE 2 Mean (range) study characteristics
Studies in the body mass index analyses Baseline year Age of population (yr) Length of follow-up (yr)
All studies (N ¼ 31)a 1981 (1958-1996) 51.5 (35.0-73.0) 15.0 (1.2-35.0)
Studies 1985 (N ¼ 16) 1973 (1958-1985)* 48.1 (35.0-71.1)* 20.8 (6.0-35.0)*
Studies >1985 (N ¼ 15) 1989 (1986-1996) 55.1 (43.4-73.0) 8.9 (1.2-15.8)
Studies in the overweight and obesity analyses
Total (N ¼ 20)a 1983 (1969-1996) 51.0 (35.0-73.0) 15.2 (1.2-33.0)
Studies 1985 (N ¼ 10) 1976 (1969-1985)* 47.1 (35.0-71.1) 21.3 (15-33.0)*
Studies >1985 (N ¼ 10) 1989 (1986-1996) 54.8 (43.4-73.0) 9.0 (1.2-15.8)
*Significant difference between calendar period strata: P < 0.05.
aThe mean study characteristics did not change substantially in the subset of studies used in the model with additional adjustments for physical activity, blood pressure
and cholesterol, although the range was slightly reduced with 4 years in baseline year and follow-up period.
TABLE 3 Relative risks (RR) of coronary heart disease per five body mass index-unit increment, overweight and obesity and
the percentage change by covariates: calendar period, age of the population and length of follow-up
Percentage
change (95% CI) in
relative risks (%)c
BMI measure
of interest
Model
(nstudies)
Meta-regression
analysisa
Pooled RRb
(95% CI)
Calendar period
(>1985 v 1985)
Age of population
(per 10 yr increment)
Length of follow-up
(per 10 yr increment )
Continuous 5-BMI-unit
increment
1 (n ¼ 31)d Univariate analysis 1.28 (1.22:1.34) 31 (56:0) 32 (52: 13) 25 (0:52)
Multivariate analysis - 9 (41:36) 29 (55: 5) -
2 (n ¼ 21) Univariate analysis 1.16 (1.11:1.21) 36 (78:15) 44 (90: 4) 6 (29:52)
Multivariate analysis - 10 (61:84) 40 (105:6) -
Overweight 1 (n ¼ 20)d Univariate analysis 1.31 (1.22:1.41) 27 (70:34) 48 (87: 12) 22 (19:78)
Multivariate analysis - 20 (44:145) 55 (128: 11) -
2 (n ¼ 14) Univariate analysis 1.17 (1.11:1.23) 6 (82:148) 24 (148:51) 12 (50:49)
Multivariate analysis - 21 (87:260) 30 (220:52) -
Obesity 1 (n ¼ 20)d Univariate analysis 1.78 (1.55:2.04) 51 (78: 14) 43 (72: 13) 53 (9-109)
Multivariate analysis - 32 (68:26) 31 (66:3) -
2 (n ¼ 14) Univariate analysis 1.49 (1.32:1.67) 51 (96:10) 42 (135:28) 29 (21:104)
Multivariate analysis - 45 (97:40) 25 (107:39) -
Model 1: the RRs are adjusted for age, sex and smoking at baseline.
Model 2: Model 1 with additional adjustment physical activity, blood pressure and cholesterol at baseline.
aUnivariate analysis: calendar period, age and follow-up period in separate models; Multivariate analysis: calendar period and age adjusted for each other.
bThe pooled RR (intercept) changed slightly in the meta-regression analysis, but not substantially with regard to the magnitude of the RR.
cIndicates the percentage change in RR of BMI or BMI category on CHD associated with the specified change in each study characteristic
dThe results of percentage change in the age, sex and smoking adjusted RR by each study characteristic in the univariate and multivariate were in the same order when
examining this in the subset of studies used in model 2.
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period. In this subset, the results for calendar period and age of the
population were similar (data not shown).
Also, to take both baseline year and length of follow-up into account
together with age of the population, we repeated the analyses with
the variables age of the population and half of the follow-up length
added up to baseline year. Then, calendar period had not an influ-
ence on the association between BMI and CHD in the univariate or
multivariate analysis, while the influence of age of the population
remained the same (data not shown).
Relative risks additionally adjusted for physical activity,
blood pressure and cholesterol. When the RRs were additionally
adjusted for physical activity, blood pressure and cholesterol, the
univariate analysis indicated no longer a significant influence of
TABLE 4 Relative risks (RR) of CHD per five BMI-unit increment, overweight and obesity stratified by calendar period
(>1985 v 1985)
BMI measure of
interest Model (nstudies)
Pooled RR (95% CI)a
Calendar period 1985 Calendar period >1985
Continuous 5-BMI-unit
increment
1 (n ¼ 31) 1.33 (1.27:1.41) 1.23 (1.16:1.31)
2 (n ¼ 21) 1.19 (1.13:1.24) 1.12 (1.04:1.20)
Overweight 1 (n ¼ 20) 1.35 (1.23:1.48) 1.25 (1.11:1.42)
2 (n ¼ 14) 1.17 (1.10:1.24) 1.18 (1.03:1.35)
Obesity 1 (n ¼ 20) 2.05 (1.75:2.40) 1.51 (1.26:1.81)
2 (n ¼ 14) 1.57 (1.39:1.78) 1.28 (1.04:1.58)
Model 1: the RRs are adjusted for age, sex and smoking at baseline.
Model 2: Model 1 with additional adjustment physical activity, blood pressure and cholesterol at baseline.
aCalculated from the univariate meta-regression analysis including calendar period, see explanation in text and Table 3 for the percentage difference between calendar
periods.
FIGURE 1 Relative risks of coronary heart disease per increment of 5 kg m2, adjusted for age, sex and smoking. Horizontal
lines indicate 95% confidence intervals.
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calendar period on the associations between a five-BMI-unit incre-
ment and CHD and obesity and CHD, but the percentage changes
remained in the same order of magnitude (36% (95%CI: 78:15)
and 51% (95%CI: 96:10), respectively) (Tables 3 and 4). Age of
the population remained significant for the association between a
five-BMI-unit increment and CHD (44% (95%CI: 90: 4), but
not for overweight and obesity (Table 3).
The multivariate analysis indicated that age of the population did
not significantly influence the association between overweight or
obesity and CHD, but a trend was still visible for the association
between a five-BMI-unit increment and CHD (40% (95%CI:
105:6)) (Table 3).
Length of follow-up had no longer a significant influence on the
association between a five-BMI-unit increment and CHD and obe-
sity and CHD (Table 3).
Because we used two endpoints, we examined whether there was a
difference between incidence and mortality regarding the RR of
BMI (categories). We found no differences and also the influence of
calendar period, follow-up period or mean age on the RR did not
differ by the endpoint used in the analyses (data not shown).
Discussion
In this meta-analysis of 31 cohorts worldwide including 389 212
mainly Caucasian persons and 20 652 CHD events, we explored the
hypothesis whether the RR of CHD associated with BMI is lower in
later studies compared to earlier studies. Further, we took other im-
portant study characteristics, i.e., age of the population and length of
follow-up into account. By taking these study characteristics into
account and carrying out extra analyses with RRs adjusted for CHD
risk factors, we found no longer a difference in the RR of CHD
associated with BMI between calendar periods. The most important
and consistent cohort characteristic influencing the association
between BMI and CHD was age of the population.
Strengths and limitations
The strength of our analysis lies in the large number of cohorts
including populations from various countries and the systematic
adjustments for relevant cohort variables (i.e., length of follow-up
and age of the population). No indication of publication bias was
found, as was discussed also in a previous publication (17).
Another strength of our meta-analysis is that we were able to
account for CHD risk factors (i.e., physical activity, blood pressure,
and cholesterol) which could influence the change in the association
between BMI and CHD over time.
Several limitations should be addressed. First, we did not use studies
with a baseline year in the 21st century. This limited our time span
to examine the influence of calendar period and to give insight on
recent developments of the association between BMI and CHD. Sec-
ond, length of follow-up was found to be a strong confounder, but
was also strongly correlated with baseline year and associated with
the RR of CHD for BMI (categories). However, in a previous analy-
sis of data from the NHANES study, adjustment for length of fol-
low-up did not affect the outcome of the trend of decreasing RRs of
all cause mortality for obesity over time (13). Third, for some stud-
ies the RRs for categories of BMI were transformed to RRs for BMI
as a continuous variable, which may have introduced some inaccur-
acy. Finally, we did not adjust for important confounders such as
dietary variables or weight (loss) history because these were not
available in most studies although those have been shown to be
related to BMI and CHD (56,57). Nevertheless, in the Nurses’ Health
Study (the largest included study) adjustment for diet had virtually
no impact on the association between BMI and risk of CHD (42).
Findings in the context of the literature
We found increased RRs of CHD for a five-BMI-unit increment,
overweight and obesity of 1.28, 1.31, and 1.78, respectively. The
accompanying RRs with the additional adjustments were 1.16, 1.17,
and 1.49, respectively. This corresponds well with relative risks
found in other studies (58-61).
With regard to time-dependent changes in the association between
obesity and health risks, a previous meta-analysis found in over-
weight and obese elderly an RR of total mortality of 0.47
(0.40:0.55) and 0.66 (0.51:0.71), using five cohorts starting in or af-
ter 1990 (62). In 13 and 15 cohorts starting before 1990, they found
respectively an RR of 1.00 (0.96:1.04) and 1.02 (0.98:1.07) (62). In
the National Health and Nutrition Examination Surveys (NHANES
I, II and III), a similar trend of decreasing RR of total mortality in
obese US adults (25 years) was found (13). Our results also indi-
cated an association between calendar period and the RR of CHD
for (increasing) BMI and obesity, but not when study characteristic
mean age of the population was taken into account. In addition, we
expected that the influence of calendar period would be attenuated
by the additional adjustments for physical activity, blood pressure
and cholesterol, because of the hypothesis that the blood pressure
and cholesterol profile in persons were unfavorable at baseline in
studies starting before 1985 compared to studies starting after 1985
due to improvements of treatment of CHD risk factors and lifestyle.
However, after the additional adjustments in the univariate analysis,
the magnitude of the percentage changes on the RRs for a five-
BMI-unit increment and obesity remained in the same order as for
the age, sex and smoking adjusted RRs.
In summary, we did not find a clear difference between calendar
periods in the association between BMI and CHD. This suggests
that earlier studies may not be ruled out for use in predictive models
forecasting future deaths of chronic diseases. However, as discussed
before, length of follow-up and age of the population might have
confounded our results, since these factors were different between
calendar periods. Therefore, we cannot conclude beyond doubt that
there is no difference between calendar periods. To examine changes
by calendar period more thoroughly, a meta-analysis should be per-
formed with similar study characteristics to exclude this kind of con-
founding. Also, systematic adjustments including information on
medication use should be considered to test our hypothesis.
Nevertheless, our study yields sufficient evidence to draw the con-
clusion that age of the population is an important factor modifying
the association between BMI and CHD. Throughout all analyses we
found a significant influence of age of the population on the associa-
tion between BMI and CHD, except in the univariate and multivari-
ate analyses with CHD and overweight and obesity adjusted for the
additional CHD risk factors. These exceptions can easily be
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explained by the low number of included studies with an old popu-
lation (N ¼ 1), which in turn made it less accurate to regress the log
RR on age for the higher age ranges. All together, our results stress
the importance of taking age of a population into account in predic-
tive models forecasting future deaths attributable to overweight and
obesity.
The decrease in RR of CHD for a five-BMI-unit increment with
each 10 year increment of age was comparable to previous studies
who found a decreasing trend in the RR of CHD associated with
BMI with increasing age (58,63). An explanation for the reduction
in RR at higher BMI levels with increasing age is complicated. In
the elderly, the value of BMI as an indicator of body fatness is
reduced because of the higher total fat mass (because of an age-de-
pendent loss of lean body mass), fat redistribution and age-related
decline in height (64). Unintentional age-related weight loss which
might be caused by (un)diagnosed illnesses can confound the associ-
ation between BMI and risk of disease/mortality in the elderly (64).
Also, the ones susceptible for the consequences of obesity might
have died earlier in life, while the remaining obese elderly persons
survived (64). Furthermore, several studies reported that the lowest
mortality from all-causes or CVD in elderly persons lies within the
overweight category, which indicates that a BMI of 18.5-24.9 kg
m2 is not appropriate for the elderly (65-67) and therefore another
anthropometric measure such as waist circumference, waist-hip ratio,
body fat or lean body mass might be more useful (68,69).
Conclusion
We found no consistent evidence for a difference in the association
between BMI and the risk of CHD by calendar period, but we can-
not conclude beyond doubt that no difference exists. Further
research, that excludes the possible influence of follow-up length, is
needed to clarify this. A clear finding of our study is, however, that
age of the population was consistently associated with the RR of
CHD for BMI. In older populations the RR of CHD associated with
BMI is lower than in younger populations. Therefore, for models
used to predict mortality and prevalence of CHD in general popula-
tions, for example as used by the WHO, data from earlier studies
may not be ruled out completely, but applying an age specific
approach can be highly recommended.
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Appendix 1: Funnel plot for age, sex, and
smoking-adjusted (log) relative risks vs
precision
Obesity Calendar Period, BMI, and CHD de Hollander et al.
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FIGURE 1 Relative risks of CHD for a five-unit-BMI increment adjusted for age, sex and smoking (N ¼ 31) plotted against year of baseline (A), age of the popu-
lation (B), and follow-up period (C) stratified by calendar period (1985 vs >1985).
Appendix 2: Relative risks of coronary heart disease (CHD) associated with body
mass index (BMI) graphically displayed against study characteristics.
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FIGURE 2 Relative risks of CHD for overweight adjusted for age, sex and smoking (N ¼ 20) plotted against year of baseline (A), age of the population (B), and
follow-up period (C) stratified by calendar period (1985 vs >1985).
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FIGURE 3 Relative risks of CHD for obesity adjusted for age, sex and smoking (N ¼ 20) by year of baseline (A), age of the population (B), and follow-up period
(C) stratified by calendar period (1985 vs >1985).
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FIGURE 4 Relative risks of CHD for a five-unit-BMI increment adjusted for age, sex, smoking, physical activity, blood pressure, and cholesterol (N ¼ 21) plotted
against year of baseline (A), age of the population (B), and follow-up period (C) stratified by calendar period (1985 vs >1985)
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Obesity Calendar Period, BMI, and CHD de Hollander et al.
FIGURE 5 Relative risks of CHD for overweight adjusted for age, sex, smoking, physical activity, blood pressure and cholesterol (N ¼ 14) plotted against year of
baseline (A), age of the population (B) and follow-up period (C) stratified by calendar period (1985 vs >1985).
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FIGURE 6 Relative risks of CHD for obesity adjusted for age, sex, smoking, physical activity, blood pressure and cholesterol (N ¼ 14) plotted against year of
baseline (A), age of the population (B) and follow-up period (C) stratified by calendar period (1985 vs >1985).
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